A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Recruiting · NCT07160634 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 3 | 2026-09-28 | NCT07160634 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Solid Biosciences Inc. | 5 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alberta Children's Hospital | Calgary | Canada | 70 |
| Arkansas Children's Hospital | Little Rock | United States | 82 |
| BC Children's Hospital | Vancouver | Canada | 10 |
| Children's Hospital of The King's Daughters | Norfolk | United States | 7 |
| Neurology Rare Disease Center | Flower Mound | United States | 1 |
| The Children's Hospital of Westmead | Sydney | Australia | 1 |
| The Hospital for Sick Children (SickKids) | Toronto | Canada | 2 |